Letters sent to healthcare professionals in November 2015
In November, letters were sent regarding thalidomide, mycophenolate mofetil, nicorandil, InductOs, and dimethyl fumarate
A summary of letters sent to healthcare professionals in November 2015 to inform of safety for:
- Thalidomide (): reduced starting dose in patients older than age 75 years (see also this month’s article)
- Mycophenolate mofetil (): pregnancy-prevention advice (see also this month’s article)
- Nicorandil (): second-line treatment for angina; risk of progressive ulceration
- .: supply shortage
- Dimethyl fumarate (): new measures to minimise the risk of progressive multifocal leukoencephalopathy